Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose the higher the rate of overtreatment
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Congenital hypothyroidism (CH) is the most frequent endocrine disorder during the neonatal period, and a delay in diagnosis and treatment leads to irreversible complications. A high L-thyroxine (LT4) dose is recommended for treatment, while the optimal starting dose is still a matter of debate. The objective of this study was to determine the effects of various starting doses of LT4 on serum thyroid stimulating hormone (TSH) and thyroxine (fT4) at the end of the first month of treatment. A total of 71 patients (37 males, 52.1%) with CH were included in the study. The patients were designated into three sets of subgroups according to the following categorical variables: (i) The mean age of the study population was 22.3±13.2 days at diagnosis. At diagnosis, the mean fT4 was 0.84±0.32 ng/dL, and TSH was 39.3±30 μIU/mL. The mean initial dose of LT4 was 10.9±2.9 μg/kg/day. Overtreatment rates were significantly higher in the highest dose group (12–17 μg/kg/day) compared with the lowest dose group (6–9.9 μg/kg/day) (61.5% and 25%, respectively, p<0.05). None of the patients was undertreated. In this study, we found that the rate of overtreatment was significantly higher in patients who were given LT4 doses of 12–17 μg/kg/day. Thus, monitoring thyroid functions earlier than one month of treatment is necessary.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the highest doses within the recommended range of 10–15 μg/kg per day resulted in more dose adjustments because of hyperthyroxinemia (105–107);”
Citations
Cites
2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Dubuis, J. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.1.222 · Cited by 194
Tillotson, S. L., Fuggle, P. W., Smith, I., Ades, A. E., & Grant, D. B. (1994) · BMJ · doi:10.1136/bmj.309.6952.440 · Cited by 177
Neonatal thyrotoxicosis: Intellectual impairment and craniosynostosis in later years
Daneman, D., & Howard, N. J. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80487-2 · Cited by 171
Salerno, M., Militerni, R., Bravaccio, C., Micillo, M., Capalbo, D., Di Maio, S., & Tenore, A. (2002) · Thyroid · doi:10.1089/105072502753451968 · Cited by 165 · cited 2×
“(14) identified the final height of patients who received high-dose LT4 therapy ( > 8 μg/kg/day) to be similar to that of patients who initially received low-dose LT4 therapy ( < 8 μg/kg/day).”
BackgroundResultSecond International Conference on NeonatalThyroid Screening: Progress report
Fisher, D. A. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80228-5 · Cited by 125
Simoneau-Roy, J., Marti, S., Deal, C., Huot, C., Robaey, P., & Van Vliet, G. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.021 · Cited by 123 · cited 1×
“Some studies have demonstrated that higher LT4 dose leads to improvement in cognitive scores (9, 14, 15), while internalizing behavior problems and anxiety, social withdrawal, and poorer concentration may also develop in later life (16).”
BackgroundDimitropoulos, A., Molinari, L., Etter, K., Torresani, T., Lang-Muritano, M., Jenni, O. G., Largo, R. H., & Latal, B. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31818d2030 · Cited by 114 · cited 1×
“(17) compared the IQ scores of 63 patients at 14 years old, who initially received an LT4 dose of 14.”
Early Treatment of Congenital Hypothyroidism
FISHER, D. A., & FOLEY, B. L. (1989) · Pediatrics · doi:10.1542/peds.83.5.785 · Cited by 111
Initial treatment dose of L-thyroxine in congenital hypothyroidism
Selva, K. A., Mandel, S. H., Rien, L., Sesser, D., Miyahira, R., Skeels, M., Nelson, J. C., & LaFranchi, S. H. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.128887 · Cited by 99 · cited 1×
“The high LT4 dose (50 μg/kg/day or 12–15 μg/kg/day) has been shown to result in normal serum fT4 levels within 2–3 days and TSH within 2–3 weeks (7, 8).”
Background
Research works printed but not linked: 19
- Rose, 2006, of Section on Committee on Genetics AT Update of newborn screening and therapy for congenital hypothyroidism, American Academy Pediatrics, 117
- Selva, 2002, Initial treatment dose of thyroxine in congenital hypothyroidism, J Pediatr, 141
- Salerno, 2002, Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism, Thyroid, 12
- Rose, 2006, of Section on Committee on Genetics AT Update of newborn screening and therapy for congenital hypothyroidism, American Academy Pediatrics, 117
- Kumorowicz, Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation - dependent probe amplification, J Pediatr Endocrinol Metab, 28, 2015
- Kempers, 2005, AS DA Disturbance of the fetal thyroid hormone state has long - term consequences for treatment of thyroidal and central congenital hypothyroidism, J Clin Endocrinol Metab, 4094, 10.1210/jc.2005-0197 · DOI · Paper page
- Daneman, 1980, Neonatal thyrotoxicosis intellectual impairment and craniosynostosis in later years, J Pediatr, 257, 10.1016/S0022-3476(80)80487-2 · DOI · Paper page
- Vaidyanathan, 2012, In congenital hypothyroidism an initial thyroxine dose of mug kg day is sufficient and sometimes excessive based on thyroid tests month later, J Pediatr Endocrinol Metab, 25, 10, 10.1515/jpem-2012-0025 · DOI · Paper page
- Campos, 1995, Outcome of lower thyroxine dose for treatment of congenital hypothyroidism, Clin Pediatr, 20, 514, 10.1177/000992289503401001 · DOI · Paper page
- Simoneau, 2004, and behavior at school entry in children with congenital hypothyroidism treated early with high - dose levothyroxine, Cognition J Pediatr, 144
- Bongers, 2013, de de de development in congenital hypothyroidism : is overtreatment a greater threat than undertreatment, Cognitive J Clin Endocr Metab, 4499, 10.1210/jc.2013-2175 · DOI · Paper page
- Delvecchio, 2007, Longitudinal assessment of levo - thyroxine therapy for congenital hypothyroidism : relationship with aetiology bone maturation and biochemical features, Horm Res, 12, 68
- Jones, 2008, Effect of high versus low initial doses of thyroxine for congenital hypothyroidism on thyroid function and somatic growth, Arch Dis Child, 940, 10.1136/adc.2007.120618 · DOI · Paper page
- Pearce, 2013, ETA Guideline management of subclinical hypothyroidism, Eur Thyroid, 28, 215, 10.1159/000356507 · DOI · Paper page
- Dubuis, 1996, Outcome of severe congenital hypothyroidism : closing the developmental gap with early high dose levothyroxine treatment, J Clin Endocr Metab, 222
- Tillotson, 1994, Relation between biochemical severity and intelligence in early treated congenital hypothyroidism : a threshold effect, Med, 309
- Fisher, 1989, DA Early treatment of congenital hypothyroidism, Pediatrics, 785, 10.1542/peds.83.5.785 · DOI · Paper page
- Fisher, 1983, DA Second International Conference on Neonatal progress report, Thyroid Screening J Pediatr, 653
- Bakker, 2002, Dynamics of the plasma concentrations of following thyroxine supplementation in congenital hypothyroidism, Clin Endocrinol, 529, 10.1046/j.1365-2265.2002.01632.x · DOI · Paper page
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
Effect of Thyroid Hormones on Neurons and Neurodevelopment
Prezioso, G., Giannini, C., & Chiarelli, F. (2018) · Hormone Research in Paediatrics · doi:10.1159/000492129 · Cited by 159
Overuse of medications in low- and middle-income countries: a scoping review
Albarqouni, L., Palagama, S., Chai, J., Sivananthajothy, P., Pathirana, T., Bakhit, M., Arab‐Zozani, M., Ranakusuma, R. W., Cardona, M., Scott, A. M., et al. (2023) · Bulletin of the World Health Organization · doi:10.2471/blt.22.288293 · Cited by 91
Aleksander, P. E., Brückner-Spieler, M., Stoehr, A.-M., Lankes, E., Kühnen, P., Schnabel, D., Ernert, A., Stäblein, W., Craig, M. E., Blankenstein, O., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01937 · Cited by 64
Esposito, A., Vigone, M. C., Polizzi, M., Wasniewska, M. G., Cassio, A., Mussa, A., Gastaldi, R., Mase, R. D., Vincenzi, G., Pozzi, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.923448 · Cited by 39
Intellectual development in preschool children with early treated congenital hypothyroidism
Seo, M. K., Yoon, J. S., So, C. H., Lee, H. S., & Hwang, J. S. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.2.102 · Cited by 25
Dai, Y., Yang, Z., Guo, J., Li, H., Gong, J., Xie, Y., Xiao, B., Wang, H., & Long, L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.793001 · Cited by 19
Khanjani, N., Ahmadzadeh, A., Bakhtiari, B., & Madadizadeh, F. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0010 · Cited by 17
“Congenital hypothyroidism (CH) is considered as one of the most common and preventable causes of mental retardation in the world and it can be prevented only by early and timely diagnosis and treatment [2].”
BackgroundBuluş, A. D., & Tiftik, E. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0188 · Cited by 19
Uthayaseelan, K., Kadari, M., Subhan, M., Parel, N. S., Krishna, P. V., Gupta, A., & Uthayaseelan, K. (2022) · Cureus · doi:10.7759/cureus.24669 · Cited by 23
“On the other hand, higher L-T4 doses have been linked to overtreatment, which can lead to poor outcomes [55].”
BackgroundCraven, M., & Frank, G. R. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2017-0513 · Cited by 14
Niuro, L., Danner, E., Viikari, L. A., Kero, J. T., Huopio, H., Jääskeläinen, J., & Niinikoski, H. (2022) · Hormone Research in Paediatrics · doi:10.1159/000528567 · Cited by 17
He, S., Ma, X., Yang, J., & Li, L. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01061-z · Cited by 11
“9 μg/kg·d, and 12–17 μg/ kg·d) for CH treatment and showed that there was no difference in TSH levels at 1 month after treatment [17].”
BackgroundGünbey, C., Özön, A., Gonc, E. N., Alikaşifoğlu, A., Karahan, S., & Kandemir, N. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2020.2020.0194 · Cited by 4
“32 ng/dL was 16 (1-100) days, and the median time for TSH level to go below 10 mIU/L was 17 (1-88) days.”
BackgroundInfluentialKnowns and unknowns about congenital hypothyroidism: 2022 update
Itonaga, T., Hasegawa, Y., Higuchi, S., Satoh, M., Sawada, H., Shimura, K., Takahashi, I., Takubo, N., & Nagasaki, K. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0016 · Cited by 7
“(17) found that an L-T4 dose above 12.5 μg/kg/d may lead to overtreatment, while Tuhan et al. and Vaidyanathan et al. (18, 19) similarly found a risk of overtreatment in patients receiving 12–17 μg/kg/d.”
InfluentialNagendra, L., Bhavani, N., Pavithran, P. V., Shenoy, M. T., Menon, U. V., Abraham, N., Nair, V., & Kumar, H. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_314_22 · Cited by 3
“In the study by Tuhan et al ., [24] patients whose TSH levels ranged from 6 to 9.9 uIU/L received a mean dose of 8.3 µ g/kg/day and met the target goal range of treatment at 1 month.”
BackgroundMethodInfluentialShreder, E. V., Shiryaeva, T., Nagaeva, E. V., & Bezlepkina, O. B. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12703 · Cited by 3
Iatrogenic hyperthyroidism in primary congenital hypothyroidism: prevalence and predictive factors
Chooprasertsuk, N., Dejkhamron, P., Unachak, K., & Wejaphikul, K. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0152 · Cited by 1
Yang, J., Zhang, J., Zhang, Y.-H., Xu, X.-Z., Chen, H., Li, Y., Jiang, Y., Wang, Z., Zhu, B., & Li, L. (2017) · PubMed Central · doi:10.7499/j.issn.1008-8830.2017.07.003 · Cited by 1
Doğumsal Hipotiroidi ile Ebeveyn Yaşı İlişkisi
Tuhan, H. (2019) · Turkish Journal of Pediatric Disease · doi:10.12956/tchd.572367
Self-citationPark, J., Oh, J. H., Cho, M., Shim, Y. S., & Lee, H. S. (2025) · Clinical Endocrinology · doi:10.1111/cen.70034 · Cited by 2
“Higher doses have been associated with an increased risk of overtreatment [24], which in some studies has been reported to be associated with attention ‐ deficit hypersensitivity disorder (ADHD) and other potential neurologic sequelae [25, 26].”
Metadata
- Authors
- Tuhan, H., Abaci, A., Cicek, G., Anik, A., Catli, G., Demir, K., & Bober, E.
- Affiliations
- Dokuz Eylül University (TR)
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2016-01-01
- Volume
- 29
- Issue
- 2
- Pages
- 133-8
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W2411210195
- Cited by
- 21
- References
- 20
- Citations by year
- 2025: 1 · 2023: 2 · 2022: 7 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 1
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- 54th Annual ESPE
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary congenital hypothyroidism, levothyroxine, initial dose, overtreatment, thyroid-stimulating hormone, free thyroxine, dyshormonogenesis, dysgenesis, thyroid function monitoring
- MeSH terms
- Congenital Hypothyroidism, Dose-Response Relationship, Drug, Female, Humans, Male, Thyroxine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.